The Susceptible-Exposed-Infected-Recovered (SEIR) model is a natural extension of the SIR Model, accounting for a fourth category of disease state, Exposure. For this ThuRsday Tutorial, we’ll cover how to not
Top 5 Takeaways No Recent Increases in Pediatric Hepatitis or Adenovirus: Analysis of four data sources shows no recent uptick in hepatitis-associated emergency department visits, hospitalizations, liver transplants, or adenovirus
Cohort studies are a common study method throughout public health and intervention methods. By following groups of people who are alike in many ways but differ by a certain characteristic,
Top 5 Takeaways High prevalence of substance use among adults seeking treatment: In 2019, alcohol (35.8%) and cannabis (24.9%) were the substances most commonly used in the past 30 days
Top 5 Takeaways Pneumonic Plague Misdiagnosed Amidst COVID-19: An adult admitted to a Wyoming hospital for respiratory symptoms initially suspected to be COVID-19 was later confirmed to have pneumonic plague.
Top 5 Takeaways Significant Decrease in Mortality Rates Among LTCF Residents: The study found a 69% reduction in COVID-19 mortality rates among long-term care facility (LTCF) residents aged ≥65 years
Top 5 Takeaways Novel OPV2 Shows Genetic Stability: Global genomic surveillance confirms the genetic stability of the novel oral poliovirus vaccine type 2 (nOPV2), maintaining the primary attenuating site’s integrity
Top 5 Takeaways Higher Hospitalization Rates in Disability-Eligible Medicare Beneficiaries: COVID-19-associated hospitalization rates were about 50% higher in disability-eligible beneficiaries compared to those eligible due to age, with rates increasing
The Susceptible-Infected-Recovered (SIR) model is a fundamental concept in epidemiology, offering insights into how diseases spread and recede in populations over time through a relatively simply set of functions. For
Top 5 Takeaways Significant Contribution by FRPP: The Federal Retail Pharmacy Program (FRPP) partners administered 67.7% of the 59.8 million COVID-19 bivalent vaccine doses in the U.S. during the study